2[2]Ronnett BM,Zahn CM,Kurman RJ et al.Disseminated peritoneal adenomuconosis and peritoneal mucinous carcinomatosis.A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features.Site of origin.Prognosis.and relationship to pseudomyxoma peritonei [J].Am J Surg Pathol 1995;9:1390-408.
3[3]Carr NJ.Pseudomyxoma peritonei and the cytologist [J].Cytopathology 1996;7:288.
5[5]Prayson a,Hart WR,Petras RE.Pseudomyxoma peritonei.A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated oaarian tumors [J].Am J Surg Pathol 1994;18:591-603.
6[6]Ronnett BM,Kurman RJ,Zahn CM,et al.Pseudomyxoma peritonei in women:a clinicopathologic analysis of 30 cases with emphasis on site of origin,prognosis,and relationship to ovarian mucinous tumors of low malignant potential [J].Hum Pathol 1995;26:509-24.
7[7]Costa MJ.Pseudmyxoma peritonei.histologic predictors of patient survival [J].Arch Pathc Lab Med 1994;118:1215-19.
8[8]Kurita M,Komatsu H,Hata y,et al.Pseudomyoma peritonei due to adenocarcinoma of the lung:case report [J].J Gastroenterol 1994;29:344-8.
9[9]Hawes D,Robinson R,Wira R.P seudomyxoma peritonei from metastatic colloid carcinoma of the breast [J].Gastrointest Radiol 1991;16:80-2.
10[10]Chejfrc J,Rieker WJ,Jabalokow VR,et al.Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas [J].Gastroenterology 1986;90:202-5.
8Deraco M, Santoro N, Carraro O, et al. Peritoneal earcinomatosis;feature of dissemination, a review [J]. Tumori, 1999, 85(1) : 1-5.
9Shen DH, Ng Ty, Khoo US, et al. Pseudomyxoma peritonei--aheterogenous disease [J]. Int J Gynaecol Obstet, 1998, 62(2) : 173.
10Kishimoto S, Kameyama M, Kodama K, et al. A case report of malignant pseudomyxoma peritonei treated by a new modality of intraperitoheal chemo-hyperthermia [ J]. Gan to Kagaku Ryoho, 1993, 20 (11 ) : 1703.
